Smith v. Medtronic, Inc.
- Jeffrey White
- 4:22-cv-09179
- U.S. District Court · Northern District of California
- 7
In Smith v. Medtronic, Judge White denied the defendants’ motion to dismiss claims concerning a medical device that allegedly broke during surgery.
The order allows Mia Inez Smith and Makia Raquel Smith’s pleaded products-liability claims to remain pending against Medtronic, Inc., Medtronic USA, Inc., Covidien LP, and Covidien Sales LLC; it does not determine ultimate liability.
What happened
In Smith v. Medtronic, Mia Inez Smith and Makia Raquel Smith sued Medtronic, Inc., Medtronic USA, Inc., Covidien LP, and Covidien Sales LLC after a medical device allegedly broke during their father Michael Ray Smith’s surgery, causing injuries and his later death.
The plaintiffs brought strict-liability and negligence claims involving manufacturing, design, sale, recall or retrofit, and warnings. The defendants argued that the amended complaint did not provide enough facts to state a claim and was an improper “shotgun” pleading that made the allegations difficult to answer.
The court denied the defendants’ motion to dismiss. Judge Jeffrey S. White ruled that the plaintiffs had alleged enough facts to plausibly support their manufacturing-defect and failure-to-warn theories at this stage, and rejected the defendants’ shotgun-pleading argument. The court also ordered the parties to participate in a case-management conference.
The detailed version
- Smith v. Medtronic, Inc. · No. 4:22-cv-09179
- Jeffrey White
- July 28, 2023
Background
Mia Inez Smith and Makia Raquel Smith, described as daughters of Michael Ray Smith and as his successors in interest, sued after a device used during Smith’s March 7, 2022 surgery at Highland Hospital allegedly broke. According to the first amended complaint, the device fractured during the procedure, causing an avulsion injury to his left anterior descending artery, bleeding, and other complications. The complaint alleged that Smith experienced pain and suffering and died from his injuries on March 19, 2022.
The plaintiffs alleged that the device had received Food and Drug Administration clearance under the Medical Device Amendments’ Section 510(k) process based on substantial equivalence to predicate devices. They asserted claims for strict products liability based on manufacturing defect and failure to warn, and negligent products liability based on negligent design, manufacturing and sale, failure to recall or retrofit, and failure to warn.
Motion and Analysis
The defendants moved to dismiss under Federal Rules of Civil Procedure 8(a)(2) and 12(b)(6), arguing that the first amended complaint did not plead enough facts to state a plausible claim. They also argued that the complaint was an impermissible shotgun pleading. On a Rule 12(b)(6) motion, the court considers whether the complaint states a legally sufficient claim, accepting its factual allegations as true and viewing them favorably to the plaintiffs.
The court held that the plaintiffs plausibly alleged a strict-liability manufacturing-defect claim. The complaint alleged that the device was defective when it left the defendants’ possession, lacked sufficient strength to prevent breaking during foreseeable uses or misuses, fractured unexpectedly, and caused Smith’s injuries and death.
The court also found sufficient allegations for the negligent products-liability theory discussed in the opinion. The plaintiffs alleged that the defendants negligently designed, manufactured, and sold the device; failed to conduct adequate evaluation and testing; knew of reports involving serious complications; and failed to investigate, suspend distribution, recall or retrofit the device, or provide warnings.
The court further held that the plaintiffs sufficiently pleaded failure-to-warn claims under both strict-liability and negligence theories. The plaintiffs alleged that the defendants knew before Smith’s surgery that the device could break and failed to adequately warn physicians or provide instructions concerning its safe use and maintenance. The defendants’ reliance on California’s learned-intermediary doctrine did not warrant dismissal at the pleading stage.
The court separately rejected the defendants’ argument that the amended complaint was an impermissible shotgun pleading, finding that contention unpersuasive.
Disposition
The court denied the defendants’ motion to dismiss the first amended complaint. The court also ordered the parties to appear for a case-management conference on September 1, 2023, and required them to file a joint conference statement by August 25, 2023. The order addressed whether the complaint adequately stated claims at the pleading stage; it did not decide whether the defendants were ultimately liable.
Read the full 7-page opinion on CourtListener, the free public archive maintained by the Free Law Project.